The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition

John L. Niles, Erwin P. Böttinger, Guillermo R. Saurina, K. J. Kelly, Guo Li Pan, A. Bernard Collins, Robert T. McCluskey

Research output: Contribution to journalArticle

191 Citations (Scopus)

Abstract

Background: In the absence of evidence of arteritis or Wegener's granulomatosis, the syndrome of lung hemorrhage and nephritis has been commonly associated with anti-glomerular basement membrane (GBM) antibodies. However, it has been increasingly recognized that many cases are associated with antineutrophil cytoplasmic antibodies (ANCAs). Objective: To review available clinical and pathologic findings to determine the diseases accounting for lung hemorrhage and nephritis. Methods: We studied the records of 750 patients from whom serum samples were sent to our laboratory for anti-GBM antibody assays between 1981 and 1993 and found 88 patients with evidence of lung hemorrhage and nephritis. Serum samples were retested, using current methods, for anti-GBM antibodies (against noncollagenous 1 domain of the α3 chain of type IV collagen) and for antibodies to proteinase 3 and myeloperoxidase - the two types of ANCA of diagnostic value. Results: Of 88 patients with evidence of lung hemorrhage and nephritis, 48 had ANCAs, six had anti-GBM antibodies, and seven had both. In 48 patients with ANCAs, the pathologic findings that accounted for the pulmonary renal syndrome were pauci-immune necrotizing and crescentic glomerulonephritis and pulmonary capillaritis. Only eight had convincing evidence (during life) of Wegener's granulomatosis and only one other had documented arteritis. In 27 patients without ANCAs or anti-GBM antibodies, a variety of unrelated renal and pulmonary diseases were found. Conclusions: The largest group of patients who present with the syndrome of lung hemorrhage and nephritis have ANCAs and not anti-GBM antibodies. Appropriate tests for antibodies to proteinase 3, antibodies to myeloperoxidase, and anti-GBM antibodies provide reliable guides for making a diagnosis in patients with this pulmonary renal syndrome.

Original languageEnglish (US)
Pages (from-to)440-445
Number of pages6
JournalArchives of Internal Medicine
Volume156
Issue number4
StatePublished - Feb 26 1996

Fingerprint

Antineutrophil Cytoplasmic Antibodies
Nephritis
Glomerular Basement Membrane
Hemorrhage
Lung
Antibodies
Myeloblastin
Arteritis
Granulomatosis with Polyangiitis
Peroxidase
Lung Diseases
Collagen Type IV
Glomerulonephritis
Serum
Kidney

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Niles, J. L., Böttinger, E. P., Saurina, G. R., Kelly, K. J., Pan, G. L., Collins, A. B., & McCluskey, R. T. (1996). The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition. Archives of Internal Medicine, 156(4), 440-445.

The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition. / Niles, John L.; Böttinger, Erwin P.; Saurina, Guillermo R.; Kelly, K. J.; Pan, Guo Li; Collins, A. Bernard; McCluskey, Robert T.

In: Archives of Internal Medicine, Vol. 156, No. 4, 26.02.1996, p. 440-445.

Research output: Contribution to journalArticle

Niles, JL, Böttinger, EP, Saurina, GR, Kelly, KJ, Pan, GL, Collins, AB & McCluskey, RT 1996, 'The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition', Archives of Internal Medicine, vol. 156, no. 4, pp. 440-445.
Niles JL, Böttinger EP, Saurina GR, Kelly KJ, Pan GL, Collins AB et al. The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition. Archives of Internal Medicine. 1996 Feb 26;156(4):440-445.
Niles, John L. ; Böttinger, Erwin P. ; Saurina, Guillermo R. ; Kelly, K. J. ; Pan, Guo Li ; Collins, A. Bernard ; McCluskey, Robert T. / The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition. In: Archives of Internal Medicine. 1996 ; Vol. 156, No. 4. pp. 440-445.
@article{48a0228d5e0442d29a60f0eed64a13e9,
title = "The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition",
abstract = "Background: In the absence of evidence of arteritis or Wegener's granulomatosis, the syndrome of lung hemorrhage and nephritis has been commonly associated with anti-glomerular basement membrane (GBM) antibodies. However, it has been increasingly recognized that many cases are associated with antineutrophil cytoplasmic antibodies (ANCAs). Objective: To review available clinical and pathologic findings to determine the diseases accounting for lung hemorrhage and nephritis. Methods: We studied the records of 750 patients from whom serum samples were sent to our laboratory for anti-GBM antibody assays between 1981 and 1993 and found 88 patients with evidence of lung hemorrhage and nephritis. Serum samples were retested, using current methods, for anti-GBM antibodies (against noncollagenous 1 domain of the α3 chain of type IV collagen) and for antibodies to proteinase 3 and myeloperoxidase - the two types of ANCA of diagnostic value. Results: Of 88 patients with evidence of lung hemorrhage and nephritis, 48 had ANCAs, six had anti-GBM antibodies, and seven had both. In 48 patients with ANCAs, the pathologic findings that accounted for the pulmonary renal syndrome were pauci-immune necrotizing and crescentic glomerulonephritis and pulmonary capillaritis. Only eight had convincing evidence (during life) of Wegener's granulomatosis and only one other had documented arteritis. In 27 patients without ANCAs or anti-GBM antibodies, a variety of unrelated renal and pulmonary diseases were found. Conclusions: The largest group of patients who present with the syndrome of lung hemorrhage and nephritis have ANCAs and not anti-GBM antibodies. Appropriate tests for antibodies to proteinase 3, antibodies to myeloperoxidase, and anti-GBM antibodies provide reliable guides for making a diagnosis in patients with this pulmonary renal syndrome.",
author = "Niles, {John L.} and B{\"o}ttinger, {Erwin P.} and Saurina, {Guillermo R.} and Kelly, {K. J.} and Pan, {Guo Li} and Collins, {A. Bernard} and McCluskey, {Robert T.}",
year = "1996",
month = "2",
day = "26",
language = "English (US)",
volume = "156",
pages = "440--445",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "4",

}

TY - JOUR

T1 - The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition

AU - Niles, John L.

AU - Böttinger, Erwin P.

AU - Saurina, Guillermo R.

AU - Kelly, K. J.

AU - Pan, Guo Li

AU - Collins, A. Bernard

AU - McCluskey, Robert T.

PY - 1996/2/26

Y1 - 1996/2/26

N2 - Background: In the absence of evidence of arteritis or Wegener's granulomatosis, the syndrome of lung hemorrhage and nephritis has been commonly associated with anti-glomerular basement membrane (GBM) antibodies. However, it has been increasingly recognized that many cases are associated with antineutrophil cytoplasmic antibodies (ANCAs). Objective: To review available clinical and pathologic findings to determine the diseases accounting for lung hemorrhage and nephritis. Methods: We studied the records of 750 patients from whom serum samples were sent to our laboratory for anti-GBM antibody assays between 1981 and 1993 and found 88 patients with evidence of lung hemorrhage and nephritis. Serum samples were retested, using current methods, for anti-GBM antibodies (against noncollagenous 1 domain of the α3 chain of type IV collagen) and for antibodies to proteinase 3 and myeloperoxidase - the two types of ANCA of diagnostic value. Results: Of 88 patients with evidence of lung hemorrhage and nephritis, 48 had ANCAs, six had anti-GBM antibodies, and seven had both. In 48 patients with ANCAs, the pathologic findings that accounted for the pulmonary renal syndrome were pauci-immune necrotizing and crescentic glomerulonephritis and pulmonary capillaritis. Only eight had convincing evidence (during life) of Wegener's granulomatosis and only one other had documented arteritis. In 27 patients without ANCAs or anti-GBM antibodies, a variety of unrelated renal and pulmonary diseases were found. Conclusions: The largest group of patients who present with the syndrome of lung hemorrhage and nephritis have ANCAs and not anti-GBM antibodies. Appropriate tests for antibodies to proteinase 3, antibodies to myeloperoxidase, and anti-GBM antibodies provide reliable guides for making a diagnosis in patients with this pulmonary renal syndrome.

AB - Background: In the absence of evidence of arteritis or Wegener's granulomatosis, the syndrome of lung hemorrhage and nephritis has been commonly associated with anti-glomerular basement membrane (GBM) antibodies. However, it has been increasingly recognized that many cases are associated with antineutrophil cytoplasmic antibodies (ANCAs). Objective: To review available clinical and pathologic findings to determine the diseases accounting for lung hemorrhage and nephritis. Methods: We studied the records of 750 patients from whom serum samples were sent to our laboratory for anti-GBM antibody assays between 1981 and 1993 and found 88 patients with evidence of lung hemorrhage and nephritis. Serum samples were retested, using current methods, for anti-GBM antibodies (against noncollagenous 1 domain of the α3 chain of type IV collagen) and for antibodies to proteinase 3 and myeloperoxidase - the two types of ANCA of diagnostic value. Results: Of 88 patients with evidence of lung hemorrhage and nephritis, 48 had ANCAs, six had anti-GBM antibodies, and seven had both. In 48 patients with ANCAs, the pathologic findings that accounted for the pulmonary renal syndrome were pauci-immune necrotizing and crescentic glomerulonephritis and pulmonary capillaritis. Only eight had convincing evidence (during life) of Wegener's granulomatosis and only one other had documented arteritis. In 27 patients without ANCAs or anti-GBM antibodies, a variety of unrelated renal and pulmonary diseases were found. Conclusions: The largest group of patients who present with the syndrome of lung hemorrhage and nephritis have ANCAs and not anti-GBM antibodies. Appropriate tests for antibodies to proteinase 3, antibodies to myeloperoxidase, and anti-GBM antibodies provide reliable guides for making a diagnosis in patients with this pulmonary renal syndrome.

UR - http://www.scopus.com/inward/record.url?scp=0030067594&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030067594&partnerID=8YFLogxK

M3 - Article

C2 - 8607730

AN - SCOPUS:0030067594

VL - 156

SP - 440

EP - 445

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 4

ER -